Marta Peri
Impact in
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
- Oncology 12
- Lung Cancer Research Studies 4
- Cancer Immunotherapy and Biomarkers 3
- PARP inhibition in cancer therapy 2
- Polyomavirus and related diseases 2
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Clara Natoli (4 shared papers)Antonino Grassadonia (4 shared papers)Michele De Tursi (4 shared papers)Vincenzo Graziano (2 shared papers)Pietro Di Marino (2 shared papers)Nicola Tinari (3 shared papers)Patrizia Vici (2 shared papers)Laura Iezzi (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Biomedicines (1 paper)npj Precision Oncology (1 paper)The Breast (1 paper)Cancers (1 paper)
- Partner nations
- ItalyIsraelUnited Kingdom
In The Last Decade
Marta Peri
19 papers receiving 283 citations
Peers
Comparison fields: 5 of 56
- Oncology 180
- Cancer Research 73
- Pulmonary and Respiratory Medicine 73
- Gastroenterology 11
- Immunology 33
Countries citing papers authored by Marta Peri
This map shows the geographic impact of Marta Peri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Peri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Peri more than expected).
Fields of papers citing papers by Marta Peri
This network shows the impact of papers produced by Marta Peri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Peri. The network helps show where Marta Peri may publish in the future.
Co-authors
The 25 scholars most cited alongside Marta Peri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 124 | |
| 2 | 2019 | 38 | |
| 3 | 2020 | 35 | |
| 4 | 2022 | 14 | |
| 5 | 2018 | 13 | |
| 6 | 2024 | 10 | |
| 7 | 2022 | 8 | |
| 8 | 1991 | 7 | |
| 9 | 2023 | 7 | |
| 10 | 2019 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2020 | 4 | |
| 13 | Helicobacter pylori infection--its prevalence and diagnosis in Israel. | 1991 | 4 |
| 14 | 2022 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2018 | 2 | |
| 17 | 2019 | 2 | |
| 18 | 2022 | 2 | |
| 19 | 2023 | 1 |
About Marta Peri
Marta Peri is a scholar working on Oncology, Epidemiology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 289 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Neuroendocrine Tumor Research Advances (3 papers), PARP inhibition in cancer therapy (2 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Treatments and Mutations (2 papers), Polyomavirus and related diseases (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (180 citations), Cancer Research (73 citations), Pulmonary and Respiratory Medicine (73 citations), Gastroenterology (11 citations) and Immunology (33 citations). Marta Peri has collaborated with scholars based in Italy, Israel and United Kingdom. Frequent co-authors include Clara Natoli, Antonino Grassadonia, Michele De Tursi, Vincenzo Graziano, Pietro Di Marino, Nicola Tinari, Patrizia Vici, Laura Iezzi, Maddalena Barba and Mario Di Gioacchino. Their work appears in journals such as Journal of Clinical Oncology, Biomedicines, npj Precision Oncology, The Breast and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.